Compare, Analyse Aurobindo Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs TEVA PHARMA (Israel) - Comparison Results

AUROBINDO PHARMA     Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AUROBINDO PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-19
TEVA PHARMA
Dec-13
AUROBINDO PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs8303,078-   
Low Rs5272,674-   
Sales per share (Unadj.) Rs333.91,766.5-  
Earnings per share (Unadj.) Rs40.4110.3-  
Cash flow per share (Unadj.) Rs51.8253.1-  
Dividends per share (Unadj.) Rs2.5096.60-  
Dividend yield (eoy) %0.43.4 11.0%  
Book value per share (Unadj.) Rs237.11,962.2-  
Shares outstanding (eoy) m585.91848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.01.6 124.8%   
Avg P/E ratio x16.826.1 64.5%  
P/CF ratio (eoy) x13.111.4 115.4%  
Price / Book Value ratio x2.91.5 195.3%  
Dividend payout %6.287.5 7.1%   
Avg Mkt Cap Rs m397,5692,438,729 16.3%   
No. of employees `00017.944.9 39.7%   
Total wages/salary Rs m25,8490-   
Avg. sales/employee Rs Th10,956.933,328.6 32.9%   
Avg. wages/employee Rs Th1,447.70-   
Avg. net profit/employee Rs Th1,324.32,082.0 63.6%   
INCOME DATA
Net Sales Rs m195,6361,497,954 13.1%  
Other income Rs m1,5530-   
Total revenues Rs m197,1891,497,954 13.2%   
Gross profit Rs m39,519410,216 9.6%  
Depreciation Rs m6,680121,081 5.5%   
Interest Rs m2,62629,422 8.9%   
Profit before tax Rs m31,767259,712 12.2%   
Minority Interest Rs m271,180 2.3%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-881-170,487 0.5%   
Tax Rs m7,269-3,171 -229.2%   
Profit after tax Rs m23,64593,576 25.3%  
Gross profit margin %20.227.4 73.8%  
Effective tax rate %22.9-1.2 -1,874.1%   
Net profit margin %12.16.2 193.5%  
BALANCE SHEET DATA
Current assets Rs m153,6451,011,713 15.2%   
Current liabilities Rs m120,429882,299 13.6%   
Net working cap to sales %17.08.6 196.5%  
Current ratio x1.31.1 111.3%  
Inventory Days Days13591 148.9%  
Debtors Days Days6496 66.4%  
Net fixed assets Rs m103,909489,265 21.2%   
Share capital Rs m5863,687 15.9%   
"Free" reserves Rs m138,3220-   
Net worth Rs m138,9081,663,943 8.3%   
Long term debt Rs m1,800765,937 0.2%   
Total assets Rs m264,5443,423,306 7.7%  
Interest coverage x13.19.8 133.3%   
Debt to equity ratio x00.5 2.8%  
Sales to assets ratio x0.70.4 169.0%   
Return on assets %9.93.6 276.4%  
Return on equity %17.05.6 302.7%  
Return on capital %23.84.9 483.4%  
Exports to sales %49.60-   
Imports to sales %18.80-   
Net fx Rs m56,7270-   
CASH FLOW
From Operations Rs m16,220238,696 6.8%  
From Investments Rs m-28,768-84,580 34.0%  
From Financial Activity Rs m19,191-286,332 -6.7%  
Net Cashflow Rs m6,656-132,216 -5.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 73.74 Rs / USD

Compare AUROBINDO PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare AUROBINDO PHARMA With: AJANTA PHARMA  SUN PHARMA  NOVARTIS  UNICHEM LAB  ALEMBIC PHARMA  



Today's Market

Sensex Ends Flat; Maruti Suzuki Rallies 7.5%(Closing)

After opening the day at record high levels, Indian share markets erased gains as the session progressed and ended on a flat note, led by a decline in IT stocks and index heavyweight HDFC Bank.

Related Views On News

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

AUROBINDO PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of AUROBINDO PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

It's Time to Book Profits (Fast Profits Daily)

Nov 27, 2020

In my first video on Equitymaster, I want to introduce you my proprietary greed and fear index. It's telling us to book some profits in the market.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

Create Wealth for Yourself in India's Drone Revolution (Profit Hunter)

Nov 27, 2020

The Chinese drone market is 14 times that of India's. Billions may flow into Indian drone companies too. Don't miss out on this wealth creating opportunity.

The Price of Dying, the Cost of Living (The Honest Truth)

Nov 20, 2020

Ajit Dayal presents a cost benefit analysis of the various types of response to covid around the world.

More
-->

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

AUROBINDO PHARMA SHARE PRICE


Dec 3, 2020 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

FEATURED VIDEOS

Adani Green: A Future Multibagger or a Big, Speculative Bubble

Is M&M the ITC of Auto Sector?

Don't Let Brokerages Fool You into Buying HUL & Nestle. The Real Money is in These Stocks Right Now...

What to Expect from Stocks during Covid Second Wave?

More Featured Videos

MARKET STATS